Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Pittenger C

14 indexed publications match this author name.

ORCID: 0000-0003-2117-9321
OpenAlex: https://openalex.org/A5001094886

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

OCD 11 Mechanism of Action 8 Safety 8 Receptor Pharmacology 3 Emotional Processing 3 Animal Study 2 Neuroplasticity 2 Depression 2 Anxiety 2 Pharmacology 2 Randomized Controlled Trial 2 Review Article 2

Journals

PsyArXiv 5 Frontiers in psychiatry 4 bioRxiv 2 Molecular Psychiatry 1 Psychiatry research 1 Heliyon 1

Publication history

α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in miceMolecular Psychiatry · 2026-07-07 Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant responsebioRxiv · 2026-03-10 Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCDPsyArXiv · 2026-02-11 Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis.Frontiers in psychiatry · 2025-01-01 Mechanisms of therapeutic change after psychedelic treatment in OCD.Psychiatry research · 2024-06-01 Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2024-01-01 Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCDPsyArXiv · 2023-03-17 Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCDPsyArXiv · 2023-03-17 Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.Frontiers in psychiatry · 2023-01-01 Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Frontiers in psychiatry · 2023-01-01 Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report.Heliyon · 2022-12-01 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in micebioRxiv · 2022-11-03 Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355PsyArXiv · 2022-10-05 Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355PsyArXiv · 2022-10-05

Author directory